On Friday, September 28, the European Commission announced that it has set a deadline of November 6 for its decision on Japanese pharmaceutical company Takeda’s US$62 billion takeover of UK Shire.
The proposed deal has already received unconditional approval from the US, Brazil, and China. The EU may approve the deal as-is, with conditions, or open a four month probe if there are serious concerns.
Also on Friday, Takeda announced that its shareholders will vote on October 19 on the Shire acquisition.
Full Content: The Pharma Letter, Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
